Maintenance bronchodilator treatment to relieve symptoms in adult research hub

A randomized, single dose, cross-over, replicated, open-label bioequivalence study comparing indacaterol/glycopyrronium (85/43mcg inhalation powder hard capsules) (PG341 [Celon Pharma] vs Ultibro Breezhaler [Novartis])

This study compares a new version of lung medicine (from Celon Pharma) with one already available (Ultibro Breezhaler) for adults with COPD. It checks if both medicines work in the same way to help breathing.